Startup Vitalunga creates novel oral drug to enable disease-free aging; pre-clinical studies expected to begin in near future
/PRNewswire/ -- Vitalunga, the biotech startup based on the research led by Professor Einav Gross and Professor Shmuel Ben-Sasson of The Hebrew University's...
Source: prnewswire.com